News - Pharmaceuticals
NSW pharmacists awarded emergency dispensing special authority during COVID-19

Pharma News: The New South Wales Government extended the special authority for emergency supply of medicines without a prescription, in a move that has been welcomed by the Pharmaceutical Society of Australia (PSA).
Patients will be able to receive a maximum PBS quantity or pack size until 30th September 2020 without a prescription, where the pharmacist is satisfied there is immediate need.
The medicine must have been previously prescribed and be for the continuation of current essential treatment where it is impractical to obtain a prescription.
PSA NSW President Professor Peter Carroll said “PSA fully supports and thanks the NSW Government for this very sensible approach which will reduce the concerns of those in the community who may find it hard to access medicines in this challenging environment,” he said.
Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
“This will enable patients to still have ongoing access to their regular medicines in the event that they are not able to see their doctor for a prescription or must self-isolate.
“We are hearing from patients that their GPs are overwhelmed and can be difficult to get an appointment. This flexible approach to healthcare will ensure pharmacists can continue to support the community during the COVID-19 Pandemic.”
“As the peak national body for pharmacists, PSA has called for and worked with the NSW Government to allow the continuation of emergency dispensing that was put in place during the recent bushfire crisis to ensure patients and members of the community continue to gain access to much needed medicines.”
Customer engagement during COVID-19. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.
News - Pharmaceuticals
New vaccine guidelines risk further decline in immunisation
The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]
MoreNews - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - MedTech & Diagnostics
As insurer blame game escalates, patients miss out on the promise of private health
The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]
MoreLeadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
More